OTLK · Outlook Therapeutics, Inc. · Documents
$0.56
+0.00 (+0.39%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because our cash and cash equivalents, together with $51.1 million of net proceeds from our August 2026 Offering, will not be adequate to fund our currently planned operations through at least the 12 months from the date of this Quarterly Report, there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 18, 2026
Market Cap
$136.65M
Shares
243.45M
Volume · Oct 22
4.34M
Avg daily vol (3M)
12.55M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-01-24 | 2024-01-22 | |
| 10-K | — | 2023-12-22 | 2023-09-30 | |
| 8-K | — | 2023-12-22 | — | |
| 8-K | — | 2023-12-06 | 2023-11-30 | |
| 8-K | — | 2023-11-02 | — | |
| 8-K | — | 2023-10-20 | 2023-10-16 | |
| 8-K | — | 2023-08-30 | — | |
| 8-K | — | 2023-08-14 | — | |
| S-3 | — | 2023-08-14 | — | |
| 10-Q | — | 2023-08-14 | 2023-06-30 | |
| 8-K | — | 2023-05-16 | 2023-05-15 | |
| 10-Q | — | 2023-05-15 | 2023-03-31 | |
| 8-K | — | 2023-05-15 | — | |
| 8-K/A | — | 2023-04-03 | 2023-03-30 | |
| 8-K | — | 2023-03-30 | 2023-03-29 | |
| DEF 14A | — | 2023-02-15 | 2023-03-29 | |
| ARS | — | 2023-02-15 | 2022-09-30 | |
| 10-Q | — | 2023-02-14 | 2022-12-31 | |
| 8-K | — | 2023-02-14 | — | |
| PRE 14A | — | 2023-01-27 | 2023-03-29 | |
| 10-K/A | — | 2023-01-24 | 2022-09-30 | |
| 8-K | — | 2022-12-29 | — | |
| 10-K | — | 2022-12-29 | 2022-09-30 | |
| 8-K | — | 2022-12-23 | — | |
| 8-K | — | 2022-12-22 | — | |
| 8-K | — | 2022-11-23 | 2022-11-18 | |
| 8-K | — | 2022-08-15 | 2022-08-11 | |
| 8-K | — | 2022-08-10 | — | |
| 10-Q | — | 2022-08-10 | 2022-06-30 | |
| 8-K | — | 2022-06-17 | — | |
| 8-K | — | 2022-06-07 | 2022-06-02 | |
| 8-K | — | 2022-05-31 | — | |
| 10-Q | — | 2022-05-13 | 2022-03-31 | |
| 8-K | — | 2022-05-13 | — | |
| 8-K | — | 2022-04-22 | 2022-04-21 | |
| 8-K | — | 2022-03-31 | — | |
| 8-K | — | 2022-03-25 | 2022-03-21 | |
| 10-Q | — | 2022-02-14 | 2021-12-31 | |
| 8-K | — | 2022-02-14 | — | |
| DEF 14A | — | 2022-01-27 | 2022-03-23 | |
| 8-K | — | 2021-12-23 | 2021-12-21 | |
| 10-K | — | 2021-12-23 | 2021-09-30 | |
| 8-K | — | 2021-12-22 | — | |
| 8-K | — | 2021-11-29 | 2021-11-23 | |
| 8-K | — | 2021-11-16 | — | |
| 8-K | — | 2021-11-12 | 2021-11-08 | |
| 10-Q | — | 2021-08-13 | 2021-06-30 | |
| 8-K | — | 2021-08-13 | — | |
| 8-K | — | 2021-08-03 | — | |
| 8-K | — | 2021-07-30 | 2021-07-27 |
Showing 101–150 of 193 filings
Key facts
CIK
1649989
CUSIP
69012T305
13F (30d)
21 filings
10 filers
Visit website
Investor relations